Brief: Transgene H1 Operating Revenues Amounted To 4.9 Million Euros

Transgene SA

18/09/2019 18:06

Sept 18 (Reuters) - Transgene SA  TRNG.PA :
    * TRANSGENE CONFIRMS THE TIMELINE OF ITS CLINICAL NEWS FLOW
AND
PRESENTS 2019 HALF-YEAR RESULTS
    * FINANCIAL VISIBILITY UNTIL 2022, FOLLOWING EUR 48.7
MILLION
RIGHTS ISSUE
    * OPERATING REVENUES AMOUNTED TO EUR 4.9 MILLION FOR FIRST
SIX
MONTHS OF 2019
    * NET LOSS AMOUNTED TO EUR 15.3 MILLION FOR FIRST HALF OF
2019
    * AS OF JUNE 30, 2019, COMPANY'S CASH, CASH EQUIVALENTS AND
OTHER
FINANCIAL ASSETS AMOUNTED TO EUR 12.8 MILLION
    * CASH BURN AMOUNTED TO EUR 4.1 MILLION IN FIRST HALF OF
2019

Source text for Eikon:  ID:nBw8KGc14a 
Further company coverage:  TRNG.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))